Macrophage‐to‐Myofibroblast Transdifferentiation Contributes to Pulmonary Fibrosis via the MERTK‐SPP1‐SRC‐TKS5 Signaling Axis
Advanced Science · 2026
DOI: 10.1002/advs.75620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yungeng Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Gua…. Hauptthemen laut MEDLINE: Cell Transdifferentiation, c-Mer Tyrosine Kinase, Myofibroblasts, Macrophages. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, R&D Program of Guangzhou National Laboratory, Project supported by Guangzhou National Laboratory and State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
In recent years, macrophage‐to‐myofibroblast transdifferentiation (MMT) has been found in fibrosis‐related diseases. We confirmed the presence of MMT in human idiopathic pulmonary fibrosis (IPF) lungs and bleomycin‐induced murine model using immunological and molecular methods. Mechanistically, ligand (GAS6)‐mediated activation of MERTK on macrophages initiates a sequential signaling cascade involving SPP1, SRC, and TKS5, which collectively drives the transdifferentiation program. Conversely, knockout of MERTK specifically in macrophages or adeno‐associated virus (AAV)‐mediated knockdown of TKS5 effectively disrupted this MERTK‐SPP1‐SRC‐TKS5 axis, potently suppressing MMT in vitro and in vivo. These interventions significantly attenuated the progression of pulmonary fibrosis, as evidenced by comprehensive assessments including microCT, pulmonary function test, and histopathological analysis. Our findings establish MMT as a key pathogenic mechanism and identify the MERTK‐initiated signaling axis as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital…
- Guangzhou National Laboratory, Guangzhou, China.
ORCID-Profile: Yungeng Wei, Xiao Xiao Tang
Förderung
- National Natural Science Foundation of China
- R&D Program of Guangzhou National Laboratory
- Project supported by Guangzhou National Laboratory and State Key Laboratory of Respiratory Disease
- National Science and Technology Major Project for Innovative Drug Development
- Guangzhou Institute of Respiratory Health Open Project
Zitieren
APA
Wei, Y., Guo, H., Yang, X., & Tang, X. X. (2026). Macrophage‐to‐Myofibroblast Transdifferentiation Contributes to Pulmonary Fibrosis via the MERTK‐SPP1‐SRC‐TKS5 Signaling Axis. Advanced Science. https://doi.org/10.1002/advs.75620
Vancouver
Wei Y, Guo H, Yang X, Tang XX. Macrophage‐to‐Myofibroblast Transdifferentiation Contributes to Pulmonary Fibrosis via the MERTK‐SPP1‐SRC‐TKS5 Signaling Axis. Advanced Science. 2026. doi:10.1002/advs.75620
BibTeX
@article{Wei2026,
author = {Wei, Yungeng and Guo, Hua and Yang, Xiangsheng and Tang, Xiao Xiao},
title = {Macrophage‐to‐Myofibroblast Transdifferentiation Contributes to Pulmonary Fibrosis via the MERTK‐SPP1‐SRC‐TKS5 Signaling Axis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75620}
}
EUVIMED